Jagsonpal Pharmaceuticals Ltd. company information, Employees & Contact Information

We Take A Look At Why Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) CEO Compensation Is Well Earned simplywall.st

Jagsonpal Pharmaceuticals appoints Amrut Medhekar as Chief Operating Officer Indian Pharma Post

USFDA pulls up Jagsonpal Pharmaceuticals for manufacturing lapses at API plant The Economic Times

Jagsonpal Pharmaceuticals allots 93,445 equity shares under ESOP Business Standard

Market Might Still Lack Some Conviction On Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM) Even After 33% Share Price Boost simplywall.st

Jagsonpal Pharmaceuticals posts Q4 FY25 PAT at Rs. 6.58 Cr Indian Pharma Post

Jagsonpal Pharmaceuticals 1:2.5 stock split record date tomorrow. Do you own? The Economic Times

Jagsonpal Pharmaceuticals Q1 FY26 revenue up 23.1% Indian Pharma Post

Jagsonpal Pharma shares jump 10% after stellar Q3 results; know more Business Standard

Jagsonpal Pharmaceuticals Hits Day Low Amid Price Pressure, Drops to Rs 213.25 Markets Mojo

Jagsonpal Pharmaceuticals Appoints Amrut Medhekar as Chief Operating Officer scanx.trade

Jagsonpal Pharmaceuticals record date for 1:2.5 stock split today The Economic Times

Stocks to Watch, Feb 24: Britannia, BPCL, Mannapuram Fin, HCG, Jagsonpal Business Standard

Jagsonpal Pharmaceuticals appoints Sachin Jain as CFO Indian Pharma Post

Private equity firms are Jagsonpal Pharmaceuticals Limited's (NSE:JAGSNPHARM) biggest owners and were hit after market cap dropped ₹1.8b simplywall.st

Jagsonpal Pharma appoints Nirav Vora as CFO Business Standard

Briefs: Jagsonpal Pharmaceuticals, Dr. Reddy’s Laboratories and Akums Drugs and Pharmaceuticals Indian Pharma Post

Jagsonpal Pharma gains after reporting strong Q3 numbers Business Standard

Jagsonpal Pharmaceuticals launches QueeZy-ER Indian Pharma Post

Infinity Holding Group to acquire 43.7 per cent stake in Jagsonpal Pharma Indian Pharma Post

Jagsonpal Pharmaceuticals standalone net profit rises 102.63% in the June 2025 quarter Business Standard

Jagsonpal Pharma up 7% as co to consider Q2 results, stock-split on Oct 23 Business Standard

Jagsonpal Pharmaceuticals acquires Yash Pharma's India, Bhutan business ET HealthWorld

Stock Alert: Advait Energy Transitions, Jagsonpal Pharmaceuticals, Container Corp, IFGL Refractories Business Standard

Jagsonpal Pharmaceuticals Q1 FY25 revenues at Rs. 61.4 Crores, 41% growth over Q4 FY24 Indian Pharma Post

Sebi Bans 2 Individuals in Jagsonpal Pharma Insider Trading Case Rediff MoneyWiz

Jagsonpal Pharma introduces new product; shares rise BusinessLine

Jagsonpal Pharmaceuticals Outperforms Sector Amid Broader Market Challenges Markets Mojo

Jagsonpal Pharmaceuticals standalone net profit rises 85.35% in the March 2025 quarter Business Standard

Sebi bans 2 individuals from securities markets for 1 year in Jagsonpal Pharma insider trading case Press Trust of India

Jagsonpal Pharmaceuticals Ltd Q1 FY2025-26 net profit climbs to Rs. 10.79 crores EquityBulls

Jagsonpal Finance to Acquire Welcast Finstocks, Plans Name Change to Jagsonpal Services scanx.trade

Jagsonpal Pharmaceuticals allots 66,000 equity shares under ESOP Business Standard

Convergent Finance to acquire controlling stake in Jagsonpal Pharmaceuticals Express Pharma

Jagsonpal Pharmaceuticals Strengthens Market Footing with Yash Pharma Acquisition ThePrint

Jagsonpal Pharmaceuticals appoints Manish Gupta as the MD Indian Pharma Post

Sebi Imposes One-Year Ban on Two Individuals for Insider Trading in Jagsonpal Pharmaceuticals Goodreturns

Medical Representative- PUNE / Hyderabad Siasat.com

Jagsonpal Pharmaceuticals trades jubilantly on entering into agreement with Suvinys Developers Udaipur Kiran